-Nanoscale biomaterials for regenerative medicine-Lead product incorporates my PhD and postdoctoral research-First full-time staff member, spin-out phase from university

Spike Ventures is a private venture fund for Stanford alumni and friends of the community to access high-quality, diversified venture portfolios in early to growth-stage companies, many with a Stanford alumni connection. Our investors own a portfolio of ~20-30 venture investments diversified by stage, sector, and geography. The fund co-invests alongside other established venture firms. Spike Ventures is part of the Alumni Ventures family of venture funds. Alumni Ventures is… Show more Spike Ventures is a private venture fund for Stanford alumni and friends of the community to access high-quality, diversified venture portfolios in early to growth-stage companies, many with a Stanford alumni connection. Our investors own a portfolio of ~20-30 venture investments diversified by stage, sector, and geography. The fund co-invests alongside other established venture firms. Spike Ventures is part of the Alumni Ventures family of venture funds. Alumni Ventures is consistently recognized as one of the most active venture firms in the US, according to PitchBook. The firm employs over 50 full-time venture investors, has raised more than $800M, holds a rapidly growing portfolio of over 800 venture-backed companies, and counts 600,000+ community members and subscribers across all of its funds. Show less

-Scale-up manufacturing and pharmaceutical formulation of supramolecular biomaterials-Novel supramolecular strategies for orthopaedic surgery and cell transplantation

-Supramolecular self-assembly, nanomaterials characterization, regenerative biomaterials-Design processing pathways to optimize self-assembly and (biological) function

-Clinical stage development of polymer-based hyperkalemia drug candidate-Chemical assays for validation of scale-up manufacturing process-CMC (Chemistry, Manufacturing, and Controls) and IPC (In-Process Controls)-Documentation for FDA NDA (New Drug Application) submission

-Preclinical R&D for endovascular drug delivery and transcatheter aortic valve devices-Biomaterials, device polymers, drug delivery and formulation, chemical and biological assays-Market, intellectual property, and regulatory pathway research

-Image processing algorithm development for small animal microCT -Cultural exchange between Johns Hopkins and Tsinghua Universities